
Thomas Barnet
Journalist

Abivax ultimately raises $920m after a deftly executed deal
Riding positive phase III results for its drug candidate obefazimod in ulcerative colitis, the French biotech put together a financing that was warmly received in the United States. The overallotment option, fully subscribed, lifts the capital raise to $920m.
July 02, 2026 at 02:44 pm
Bouygues Construction buys U.S. firm Vannoy
Bouygues Construction has finalized the acquisition of Vannoy Construction, a company whose 2025 revenue reached the equivalent of 873m. The deal is part of Bouygues Construction's strategy of international expansion.
July 02, 2026 at 02:30 pm

2CRSi launches an independent review of its large German contract
2CRSi has initiated an independent verification process regarding the sale of 194 servers to a German customer. The audit is based on third-party confirmations from banks, the customer and carriers. Findings will be released as soon as they are available.
July 02, 2026 at 02:14 pm
Airbus and Safran Buy Out Tikehau Capital's Stake in Aubert & Duval
The two groups have signed an agreement to acquire, on an equal basis, the stake held by Tikehau Capital in Aubert & Duval. The transaction, subject to regulatory approvals, continues the turnaround under way since 2023.
June 25, 2026 at 02:51 pm
OVHcloud, lifted by Public Cloud, confirms its full-year targets
The French group posted 6.9% organic growth in fiscal Q3, supported by Public Cloud. Management is confirming its financial targets for fiscal 2026. The stock, boosted by the sovereignty theme, is already up 120% since January 1.
June 25, 2026 at 02:38 pm
Discover our authors
Chief Editor
Senior Analyst
Journalist
Analyst
Analyst
- Stock Market
- Our authors
- Thomas Barnet



























